← All organizations

Kythera

For profitContributed to NME

Also known as: Kythera Biopharmaceuticals | Kythera Biopharmaceuticals, Inc | Kythera Biopharmaceuticals, Inc. | KYTHERA BIOPHARMS

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

First marketed drug

First NDA

Last known activity

Apr 1, 2014

Acquired by Allergan PLC (2015) → AbbVie on Jan 1, 2015

Timeline

2000s

Aug 1, 2005
Kythera— Founded

2010s

Jan 1, 2015
Allergan PLC (2015)— Acquired By
Apr 29, 2015
deoxycholic acid— NDA Organization
Apr 29, 2015
deoxycholic acid— NDA Secondary Org
Jun 26, 2019
AbbVie— Now

Drugs by trial phase (6 distinct, 22 trials)

Phase 3 (5 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

moxifloxacin

Indications

Approved for

Subcutaneous Fat

Studied for

Lipoma

Marketed drugs (1)

deoxycholic acid

Recent trials (36)

NCT02123134Lead sponsorPhase 3Apr 1, 2014
NCT02163902Lead sponsorPhase 3Dec 1, 2013
NCT02035267Lead sponsorPhase 3Dec 1, 2013
NCT02007434Lead sponsorPhase 3Dec 1, 2013
NCT01706679Lead sponsorPhase 1Oct 1, 2012
NCT01632917Lead sponsorPhase 1Jun 1, 2012
NCT01632917Study directorPhase 1Jun 1, 2012
NCT01546142Lead sponsorPhase 3Mar 1, 2012
NCT01546142Study directorPhase 3Mar 1, 2012
NCT01542034Study directorPhase 3Feb 1, 2012
NCT01542034Lead sponsorPhase 3Feb 1, 2012
NCT01462786Study directorPhase 1Oct 1, 2011
NCT01462786Lead sponsorPhase 1Oct 1, 2011
NCT01426373Lead sponsorPhase 3Aug 1, 2011
NCT01426373Study directorPhase 3Aug 1, 2011

Details

Founded: Calabasas, CA, US Aug 1, 2005
First NDA: Apr 29, 2015
Last known activity: Apr 1, 2014

Notes

Allergan acquires Kythera 17 Jun 2015